40 min listen
Bruton Tyrosine Kinase Inhibitors in B-Cell Malignancies: Multidisciplinary Perspectives on Managing and Maximizing Care
FromKeeping Current
Bruton Tyrosine Kinase Inhibitors in B-Cell Malignancies: Multidisciplinary Perspectives on Managing and Maximizing Care
FromKeeping Current
ratings:
Length:
36 minutes
Released:
Nov 16, 2023
Format:
Podcast episode
Description
Do you know how adverse events (AEs) associated with Bruton tyrosine kinase (BTK) inhibitors affect patients’ lives and how best to manage these events? Credit available for this activity expires: 11/15/24 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/998369?ecd=bdc_podcast_libsyn_mscpedu
Released:
Nov 16, 2023
Format:
Podcast episode
Titles in the series (100)
Implementing Multiple Myeloma Clinical Trial Data in Real-World Practice: Experts in the field discuss how to implement the newest data in multiple myeloma into the real-world clinical practice. --- Full URLs: Earn Credit / Learning Objectives & Disclosures:... by Keeping Current